|
| Home | ● | Contact | ● | Sanquin | ● | News | ● | Jobs | ● | Sitemap | ● |
|
Diagnostic Services
|
● |
Products
|
● |
Research
|
● |
Education & Training
|
● |
Business Activities
|
Catalogue Diaclone antibody
More than twenty years of Diaclone as a centre for monoclonal antibodies (mab) in research, diagnostics and therapy. As early as February 1988 a mab of Diaclone, the CD25 or B-B10, was used in vivo to treat a severe case of acute Graft versus Host disease. Since then many other Diaclone mabs, like CD4, anti-TNF, anti-IL-6 and anti-IL-10, have been used in vivo to treat a variety of diseases. These clinical studies created worldwide collaborations with medical centres and many assays were developed to monitor the studies. Being present since the early days when therapeutic mabs were developed, Diaclone created the reputation of being the centre of excellence for mab development, a reputation we have since then maintained. This triggered another activity within Diaclone: development of mabs with precisely defined characteristics for pharmaceutical companies, either for therapeutic use or for monitoring clinical studies. These activities have left their hallmarks on the entire range of Diaclone products as outstanding quality whatever the application. Download the catalogue Read more by clicking on the PDF icon below: | |